BiotechTube
iSTAR Medical

iSTAR Medical

Wavre, Belgium· Est.
istar-medical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $60M

Overview

iSTAR Medical is a private, commercial-stage medical device company pioneering a novel approach to glaucoma surgery with its MINIject® implant. The device is made from the company's proprietary STAR® material, a soft, flexible silicone designed to encourage tissue bio-integration and enhance aqueous humor outflow via the supraciliary space. With commercial approval in the EU, UK, Switzerland, and Australia, and an ongoing FDA clinical trial in the US, the company is positioned in the high-growth MIGS segment. Its strategy is to become a global leader in minimally invasive implants for glaucoma surgery.

OphthalmologyGlaucoma

Technology Platform

Proprietary STAR® material: a soft, flexible, medical-grade silicone elastomer with a multi-channel network of hollow spheres designed to encourage tissue bio-integration for minimally invasive ophthalmic implants.

Funding History

2
Total raised:$60M
Series B$40M
Series A$20M

Opportunities

The global MIGS market is the fastest-growing segment in glaucoma surgery, projected at 24% annual growth.
MINIject®'s unique supraciliary approach and bio-integrating material differentiate it in a crowded field.
Successful FDA approval would provide access to the world's largest medical device market.

Risk Factors

The company faces significant regulatory risk with its ongoing FDA trial, where failure or delay would be a major setback.
As a private company commercializing against larger competitors, execution risk in sales expansion and financial risk in funding the US pathway are high.

Competitive Landscape

iSTAR Medical competes in the crowded MIGS market against established players like Alcon (Hydrus Microstent), Glaukos (iStent), and Santen (PRESERFLO). Its key differentiation is the supraciliary placement and the proprietary STAR® bio-integrating material, aiming for sustained efficacy and a favorable safety profile.

More companies in Drug Delivery & Formulation →More companies in Belgium →